Codergocrine Mesylate

Mild to moderate dementia
Adult: 3-4.5 mg daily. May also be given via sublingual admin.
Warnings / Precautions
Pregnancy. Severe bradycardia.
Adverse Reactions
Abdominal cramps, nausea, vomiting, headache, blurred vision, skin rashes, nasal congestion, flushing of the skin, dizziness, orthostatic hypotension, bradycardia.
Mechanism of Actions
Co-dergocrine mesylate is a complex of 4 hydrogenated ergot alkaloids.It acts at the central synapsi causing dopaminergic and serotonergic actions while reducing noradrenergic activity in the limbic and other areas. Age-related symptoms and signs such as loss of recent memory, confusion, poor concentration, disorientation, apathy, depression, difficulty in self-care and unsociability are improved.
Absorption: Oral: Rapidly absorbed from the GI tract; plasma levels peak about 1-2 hr after a dose.
Distribution: 81% bound to plasma proteins.
Metabolism: Extensive first-pass effect.
Excretion: Mainly in bile via the faeces, via urine (small amounts); elimination T1/2 (biphasic): 1.5-2.5 hr (α-phase), 13-15 hr (β-phase).
Storage Conditions
Oral: Store below 25°C.
ATC Classification
C04AE04 - dihydroergocristine ; Belongs to the class of ergot alkaloids. Used as peripheral vasodilators.
Oral: Store below 25°C.
Available As
  • Codergocrine Mesylate 0.3 mg
  • Codergocrine Mesylate 1 mg
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Codergocrine Mesylate

    Codergocrine Mesylate Containing Brands

    We are Developing Our database, More results coming soon.

    Codergocrine Mesylate is used in following diseases

    We are Developing Our database, More results coming soon.

    Drug - Drug Interactions of Codergocrine Mesylate

    We are Developing Our database, More results coming soon.